Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.
about
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infectionT helper cell activation and human retroviral pathogenesisCD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.Vaccinia virus vectors: new strategies for producing recombinant vaccines.Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysisAnalysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis.Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variationComparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoireNaturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccineRecognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.Peptide component vaccine engineering: targeting the AIDS virus.Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanismCytotoxic T lymphocytes and viral turnover in HIV type 1 infectionHuman immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cellsThree epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes.Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey.Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphocytes.Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificitiesGenetic control of immune responses to HIV-1 env DNA vaccine.Detection of simian immunodeficiency virus (SIV)-specific T-cell-mediated cytotoxicity in the peripheral blood from infected cynomolgus monkeys.Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection.Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.
P2860
Q24531479-BF6034CF-1718-4ECD-94D6-13206562FF73Q24645815-9F330D47-55BF-44C2-B75E-88C4CEA66FE8Q24650854-EC4B62F3-5E7E-48EB-8D2C-01193198B0F4Q33646310-156663F8-E6DF-44B4-AB12-EF3C662770C7Q33880904-6AD515E8-C787-4AC8-92EE-90C708D3F8E3Q33935668-ED7C592F-CDDA-44F2-B709-3BF1E048F8E5Q34171623-2C1E146D-F42D-42CC-B6C4-02FCBA569424Q34211635-00153DE1-3561-4173-A97D-B3BF8D7E3D76Q34323839-00503159-7BFD-49CD-8C2F-F5F706A26977Q35595915-6F31CAA1-137E-4F1A-A305-C9D6F4BB476CQ35873361-B9AC569D-9629-457C-A095-EE9976D389BDQ35980019-3C8094D7-DCDD-4090-9B60-9F18594EABBAQ36231126-D3932757-3ABE-49AD-95AC-597D92CED287Q36232089-7EC4C0A7-EF3A-47B0-8947-09B4CFA2DC75Q36350632-ABA1C33C-C98A-47C1-B473-1D3A313138DFQ36361227-A49E73D5-2ACE-4A21-B058-A0206899476BQ36362985-5494E4DA-4B16-433D-92F6-706A2BAE7259Q36363763-59456298-1971-450D-A10E-7258524671F5Q36575290-2C2D990B-796E-41E3-8B3A-FFB937445B20Q36633526-A6C2595D-FF36-468F-A652-4159FDE870BAQ36639821-D32CC28A-E382-45E0-846A-3570C1043BBAQ36687749-1D581ECA-EBE5-413B-999C-546052F237D2Q36708999-6C8A700B-C221-45B5-9AB6-411CBDD25FFFQ36820948-C9420522-620C-4919-AA67-27965D3C8739Q37092734-AAF565C1-C5AF-4D7D-BE9F-ACC52C3F3681Q37511451-C278BBB0-7BF3-48B5-A639-EE1B2BDEDD31Q37623514-77F4A1DE-2F68-4063-8FCB-702D315FEEEAQ37723559-B7CC2020-9F92-4A49-8CAA-7899CDA638ACQ39872348-44EB0B58-73DE-4D45-8F13-BDFF7288139BQ40063883-D51A6C3B-CCE4-401C-9540-81BA7F868D7DQ40066064-5B6F29BA-E311-46E6-AC69-4495BA93CFE7Q40673123-3AAD1484-B83F-4BF6-AED0-29FC0A2A80A1Q42768401-4E2CDB78-F251-4B6E-91D6-D6FDB1C998B4Q43504396-77B7823E-5D71-44D9-84FD-5FD2A17AE859Q45743573-36544218-F4DF-4FA5-A50C-EE6AEDEFC27EQ45860432-34DDC802-E665-4A5C-A1A5-4463B527BE98Q47350110-79BEC446-BCF1-4225-821D-5B9BE164EE65
P2860
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Group-specific, major histocom ...... an HIV-1-infected individual.
@ast
Group-specific, major histocom ...... an HIV-1-infected individual.
@en
type
label
Group-specific, major histocom ...... an HIV-1-infected individual.
@ast
Group-specific, major histocom ...... an HIV-1-infected individual.
@en
prefLabel
Group-specific, major histocom ...... an HIV-1-infected individual.
@ast
Group-specific, major histocom ...... an HIV-1-infected individual.
@en
P2093
P2860
P356
P1476
Group-specific, major histocom ...... an HIV-1-infected individual.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.22.8638
P407
P577
1988-11-01T00:00:00Z